Joshua G. Cohen, M.D., F.A.C.O.G., F.A.C.S.
Joshua G. Cohen, M.D. is a board-certified gynecologic oncologist dedicated to offering his patients in Orange County empathy and excellence in clinical care. Dr. Cohen is an expert in the surgical cytoreduction of cancer and in the use of minimally invasive surgical techniques, including robotic surgery. He values the opportunity to perform cancer surgery and oversee systemic treatment, developing a personalized treatment plan for each patient. Dr. Cohen provides a comprehensive approach to the management of gynecologic cancers including patients with genetic predispositions to these cancers. One of Dr. Cohen’s main goals is for his patients to have the tools to be actively engaged in their medical decisions, in a supportive environment, to maximize cancer care and quality of life.
He has been recognized by Los Angeles Magazine as one of L.A.’s Top Doctors and a Southern California Super Doctor. As Medical Director of the Gynecologic Cancer Program at the Lennar Foundation Cancer Center at City of Hope Orange County, he aims to ensure patients facing ovarian, endometrial, cervical, vulvar, and vaginal cancer receive world-class care.
Dr. Cohen attended medical school at the Northwestern University Feinberg School of Medicine. He completed his residency in obstetrics and gynecology at the University of California, San Francisco, where he received multiple awards including outstanding teaching resident. He then pursued a fellowship in gynecologic oncology at UCLA and Cedars-Sinai Medical Center. Dr. Cohen has led significant efforts in gynecologic cancer research and completed the Clinical Research Training Program at the National Institutes of Health, as well as the Clinical and Translational Science Institute certificate program at UCLA Medical Center.
An investigator with more than three dozen peer-reviewed publications, Dr. Cohen leads studies designed to improve the quality of care and outcomes for patients facing gynecologic cancer. He joined City of Hope from the David Geffen School of Medicine at UCLA, where he served as gynecologic oncology fellowship program director. Dr. Cohen is a Fellow in the American College of Obstetrics and Gynecology and a Fellow in the American College of Surgeons.
Dr. Cohen grew up in Orange County, and he considers it an honor to serve patients in the same area where he was raised. Away from the office, he enjoys spending time with his wife and fraternal twins.
Location
Newport Beach
Newport Beach, CA 92660
Orange County Lennar Foundation Cancer Center
Irvine, CA 92618
Seacliff
Huntington Beach, CA 92648
Education & Experience
- American Board of Obstetrics and Gynecology
- Gynecologic Oncology Certification
- Obstetrics and Gynecology Certification
-
2007, M.D., Feinberg School of Medicine, Northwestern University — Chicago, IL
-
2002, B.A., Political Science, Weinberg College of Arts and Sciences, Northwestern University — Evanston, IL
- 2020-2021, Fellowship, Medical Education, University of California, Los Angeles — Los Angeles, CA
- 2011-2014, Fellowship, Division of Gynecologic Oncology, University of California, Los Angeles/Cedars-Sinai Medical Center — Los Angeles, CA
- 2010, The Felix Rutledge Fellowship in Gynecologic Oncology, The University of Texas, MD Anderson Cancer Center — Houston, TX
- 2005-2006, Fellowship, Clinical Research Training Program, National Institutes of Health, National Cancer Institute — Bethesda, MD
- 2003, Summer Research Fellowship Program, National Institutes of Health, National Institutes of Health, National Cancer Institute — Bethesda, MD
- 2008-2011, Residency, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco — San Francisco, CA
- 2007-2008, Internship, Gynecology and Reproductive Sciences, Department of Obstetrics, University of California, San Francisco — San Francisco, CA
- 2022-present, Medical Director, Gynecologic Cancer Program, and Associate Clinical Professor, Gynecologic Oncology, City of Hope Orange County — Irvine, CA
- 2020-2022, Associate Clinical Professor, UCLA Medical Center — Los Angeles, CA
- 2014-2020, Assistant Clinical Professor, UCLA Medical Center — Los Angeles, CA
- 2015-2022, Staff Member, Los Robles Medical Center — Thousand Oaks, CA
- 2015-2022, Staff Member, Providence Saint John’s Medical Center — Santa Monica, CA
Awards
- 2022, Southern California Super Doctor – Los Angeles Magazine
- 2021, Southern California Super Doctor – Los Angeles Magazine
- 2020, Southern California Super Doctor – Los Angeles Magazine
- 2019, Top Doctors – Los Angeles Magazine
- 2018, American College of Obstetrics and Gynecology Mentor Award, University of California, Los Angeles, Department of Obstetrics and Gynecology
- 2018, Top Doctor – Los Angeles Magazine
- 2017, Southern California Super Doctors Rising Star – Los Angeles Magazine
- 2016, Southern California Super Doctors Rising Star – Los Angeles Magazine
- 2015, ACOG Council on Resident Education in Obstetrics and Gynecology, National Faculty Award, University of California Los Angeles, Department of Obstetrics and Gynecology
- 2014, Sports Spectacular Endowed Fellowship Award, Cedars-Sinai Medical Center
- 2014, Outstanding Fellow Teaching Award, Cedars-Sinai Medical Center
- 2008, Outstanding Resident Award in Medical Student Teaching, University of California, San Francisco, Department of Obstetrics, Gynecology, and Reproductive Sciences
- 2008, Outstanding Resident Research Award, Clinical and Translational Science Institute, University of California, San Francisco
Memberships
American Association for Cancer Research
American College of Obstetricians and Gynecologists
American College of Surgeons
American Gynecological Obstetrical Society
American Medical Association
American Society for Colposcopy and Cervical Pathology
American Society of Clinical Oncology
Society of Gynecologic Oncology
Western Association of Gynecologic Oncology
Publications
- Armstrong A, Kroener L, Cohen JG, Han CS, Nitti VW, Rible R, Brennan K. Faculty and applicant perceptions of virtual interviews on subspecialty fellowship match in obstetrics and gynecology. Med Educ Online. 2022 Dec;27(1):2068993. doi: 10.1080/10872981.2022.2068993. PubMed PMID: 35473575; PubMed Central PMCID: PMC9067945.
- Nakhla M, Eakin CM, Mandelbaum A, Karlan B, Benharash P, Salani R, Cohen JG. Frailty is independently associated with worse outcomes and increased resource utilization following endometrial cancer surgery. Int J Gynecol Cancer. 2022 Jun 20;. doi: 10.1136/ijgc-2022-003484. [Epub ahead of print] PubMed PMID: 35725031.
- Ng AP, Sanaiha Y, Verma A, Lee C, Akhavan A, Cohen JG, Benharash P. Insurance-based disparities and risk of financial toxicity among patients undergoing gynecologic cancer operations. Gynecol Oncol. 2022 Jun 1;. doi: 10.1016/j.ygyno.2022.05.017. [Epub ahead of print] PubMed PMID: 35660294.
- Eakin CM, Liao CI, Salani R, Cohen JG, Kapp DS, Chan JK. The association of obesity with type I uterine cancer-is this an oversimplification?. Am J Obstet Gynecol. 2022 May 11;. doi: 10.1016/j.ajog.2022.05.016. [Epub ahead of print] PubMed PMID: 35562051.
- Chantharasamee J, Wong K, Potivongsajarn P, Qorbani A, Motamed N, Brackert S, Cohen J, Chmielowski B, Kalbasi A, Rao J, Nelson S, Singh A. Retrospective analysis of adjuvant treatment for localized, operable uterine leiomyosarcoma. Cancer Med. 2022 Mar 20;. doi: 10.1002/cam4.4665. [Epub ahead of print] PubMed PMID: 35307963.
- Aryasomayajula C, Chanana A, Tandel M, Kwan L, Cohen JG, Lai TS, Salani R, Zakhour M. The role of high-risk HPV testing in cervical cancer surveillance. Gynecol Oncol. 2022 Feb;164(2):357-361. doi: 10.1016/j.ygyno.2021.11.014. Epub 2021 Nov 24. PubMed PMID: 34836678.
- Wong DH, Mardock AL, Manrriquez EN, Lai TS, Sanaiha Y, Sinno AK, Benharash P, Cohen JG. Trends in extent of surgical cytoreduction for patients with ovarian cancer. PLoS One. 2021;16(12):e0260255. doi: 10.1371/journal.pone.0260255. eCollection 2021. PubMed PMID: 34879081; PubMed Central PMCID: PMC8654234.
- Akametalu P, Barcelon JM, Myint O, Moatamed NA, Karlan BY, Kamrava M, Cohen JG. Vaginal high-grade sarcoma in pregnancy. Gynecol Oncol Rep. 2021 Nov;38:100881. doi: 10.1016/j.gore.2021.100881. eCollection 2021 Nov. PubMed PMID: 34926762; PubMed Central PMCID: PMC8651769.
- Mandelbaum A, Rudasil S, Aguayo E, Chan E, Sanaiha Y, Cohen JG, Benharash P. National Trends in Utilization of Episiotomy and Factors Associated with High-Utilization Centers in the United States. Journal of Women’s Health and Development. 2021 September; 4(3).
- Budker RL, Rudasill SE, Mardock AL, Nyakudarika NC, Benharash P, Cohen JG. Predictors of 30-day Readmission among Ovarian Cancer Patients Undergoing Surgery. Journal of Women's Health and Development. 2021 May. doi: 10.26502/fjwhd.2644-28840061.
- Porter A, Barcelon JM, Budker RL, Marsh L, Moriarty JM, Aguiar X, Rao J, Ghorani E, Kaur B, Maher G, Seckl MJ, Konecny GE, Cohen JG. Treatment of metastatic placental site trophoblastic tumor with surgery, chemotherapy, immunotherapy and coil embolization of multiple pulmonary arteriovenous fistulate. Gynecol Oncol Rep. 2021 May;36:100782. doi: 10.1016/j.gore.2021.100782. eCollection 2021 May. PubMed PMID: 34036138; PubMed Central PMCID: PMC8134973.
- Milki AA, Cohen JG, Mann AK, Kapp DS, Chan JK. Progress and trends in publication of oral and video presentations at the society of gynecologic oncology annual meeting from 2006 to 2016. Gynecol Oncol Rep. 2021 May;36:100758. doi: 10.1016/j.gore.2021.100758. eCollection 2021 May. PubMed PMID: 33948477; PubMed Central PMCID: PMC8080448.
- Boitano TKL, Smith HJ, Cohen JG, Rossi EC, Kim KH. Implementation and evaluation of a novel subspecialty society fellows robotic surgical course: the SGO minimally invasive academy surgical curriculum. J Gynecol Oncol. 2021 Mar;32(2):e26. doi: 10.3802/jgo.2021.32.e26. Epub 2021 Jan 8. PubMed PMID: 33470068; PubMed Central PMCID: PMC7930459.
- Milki AA, Cohen JG, Kaur Mann A, Kapp DS, Chan JK. Publication of oral and video presentations from the Society of Gynecologic Oncology annual meeting over 11 years - What characteristics were important?. Gynecol Oncol Rep. 2021 Feb;35:100688. doi: 10.1016/j.gore.2020.100688. eCollection 2021 Feb. Review. PubMed PMID: 33385054; PubMed Central PMCID: PMC7771100.
- Cinar P, Bold R, Bosslet BA, Bota DA, Burgess D, Chew HK, Cohen JG, Elquza E, Gold KA, Kamiya E, Karlan BY, McKay RR, Patel SP, Ternavan K, Welborn J, Yamamoto M, Rugo HS. Planning for post-pandemic cancer care delivery: Recovery or opportunity for redesign?. CA Cancer J Clin. 2021 Jan;71(1):34-46. doi: 10.3322/caac.21644. Epub 2020 Sep 30. PubMed PMID: 32997807; PubMed Central PMCID: PMC7537198.